Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6SF1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,183
Award facts
- Contract value 100% obligated
- $31,183.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $31.2K to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector pens. The contract is competitively awarded with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 14, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly AmerisourceBergen), one of the nation's largest pharmaceutical distributors serving federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Repatha is a PCSK9 inhibitor indicated for cholesterol management in patients with cardiovascular disease, representing the type of specialty pharmaceutical commodity that supports military treatment facilities and veteran healthcare programs under this strategic procurement vehicle.
Quick answers
Who was awarded contract SPE2DR26F6SF1?
SPE2DR26F6SF1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F6SF1 worth?
The government has obligated $31,183 on SPE2DR26F6SF1.
Is contract SPE2DR26F6SF1 an order under another contract?
Yes. SPE2DR26F6SF1 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SF1 competed?
The extent of competition for SPE2DR26F6SF1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award